Implementation Facilitation of Exercise is Medicine Greenville

NCT07340580 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2026-04-02

No results posted yet for this study

Summary

A public health priority exists for the U.S. healthcare sector to integrate physical activity (PA) as a part of the patient care model. This research will provide valuable information on facilitating optimal implementation of a clinic-to-community model that identifies, refers, and enrolls physically inactive patients to community-based PA programs for the prevention and treatment of chronic diseases. Further, this work will provide evidence on the cost-effectiveness of integrating PA in healthcare systems as a population health management strategy.

Conditions

Interventions

BEHAVIORAL

Clinic Implementation Facilitation

This single arm intervention will be applied to 35 Prisma Health primary care clinics where the EIMG model is currently activated. At six-month intervals, six or more clinics will receive tailored implementation facilitation (IF) based on pre-implementation facilitation findings at each clinic. We will explore factors related to achieving optimal implementation and reach of EIMG. Patient referral rates and health outcomes will also be captured as a result of changes of clinical workflow due to the IF.

Sponsors & Collaborators

  • University of South Carolina

    lead OTHER
  • University of South Carolina School of Medicine, Greenville

    collaborator UNKNOWN
  • University of Nebraska

    collaborator OTHER
  • University of Utah

    collaborator OTHER
  • Temple University

    collaborator OTHER
  • Prisma Health-Upstate

    collaborator OTHER
  • Durham University

    collaborator OTHER

Principal Investigators

  • Jennifer L Trilk, PhD · University of South Carolina School of Medicine, Greenville

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2029-07-31
Completion
2030-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07340580 on ClinicalTrials.gov